[Skip to Content]
[Skip to Content Landing]
Research Letter
May 2016

Communication of Recurrence Risk Estimates to Patients Diagnosed With Breast Cancer

Author Affiliations
  • 1Department of Health Behavior & Health Education, School of Public Health, University of Michigan, Ann Arbor
  • 2Division of General Medicine, Department of Internal Medicine, University of Michigan, Arbor
  • 3Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor
  • 4Cancer Surveillance & Outcomes Research Team (CanSORT), University of Michigan, North Campus Research Complex, Ann Arbor
  • 5Center for Cancer Biostatistics, Department of Biostatistics, University of Michigan, University of Michigan, Ann Arbor
  • 6Department of Radiation Oncology, University of Michigan, Ann Arbor
JAMA Oncol. 2016;2(5):684-686. doi:10.1001/jamaoncol.2015.6416

For patients with breast cancer to play active roles in treatment decisions, they must understand their risk of cancer recurrence and how that risk changes with different treatments. Such information is available to treating clinicians through tools such as AdjuvantOnline,1,2 and the use of such tools may reduce patient selection of treatments with low risk reduction.3,4 Our objective was to identify how often medical oncologists and surgeons use such tools or provide patients diagnosed as having breast cancer with detailed recurrence risk information, as well as to explore what clinician characteristics influence these behaviors.

First Page Preview View Large
First page PDF preview
First page PDF preview